Mark Olesnavage
Managing Director
Grand Rapids, Michigan, United States
10 investmentsMark Olesnavage is a Managing Director based in Grand Rapids, Michigan, United States. Mark Olesnavage has backed 10 companies, including Nymirum, Trapelo Health and Cirius Therapeutics. Investment focus areas include Health Care, Life Science and Information Services.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Portfolio Companies (10)
| Industry | Stage | Website | |||
|---|---|---|---|---|---|
| 1 | Nymirum | — | — | — | — |
| 2 | Trapelo Health | — | — | — | — |
| 3 | Cirius Therapeutics | — | — | — | — |
| 4 | Metabolic Solutions Development | — | — | — | — |
| 5 | NeoChord | — | — | — | — |
| 6 | Sierra Oncology | — | — | — | — |
| 7 | Prevacept Infection Control | — | — | — | — |
| 8 | Bjond | — | — | — | — |
| 9 | Tolera Therapeutics | — | — | — | — |
| 10 | Delphinus Medical Technologies | — | — | — | — |
Showing 1–10 of 10
Access Full Contact Information
Get Mark Olesnavage's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
No credit card required